Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000404639 | SCV000399310 | uncertain significance | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001512572 | SCV000723492 | likely benign | not provided | 2020-06-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001512572 | SCV001720017 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278448 | SCV002565320 | likely benign | Ehlers-Danlos syndrome | 2022-06-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436172 | SCV002746077 | likely benign | Cardiovascular phenotype | 2020-01-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003940260 | SCV004751654 | benign | ZNF469-related disorder | 2019-06-07 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |